Already positive, the research from JP Morgan and its analyst Douglas Anmuth still consider the stock as a Buy opportunity. The target price is decreased from USD 425 to USD 400.
In a research note, JP Morgan analyst Douglas Anmuth has maintained his recommendation on the stock with a Buy rating. The target price is still set at USD 150.